Pafolacianine Sodium

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NamePafolacianine Sodium
Drug Alias NameFolate-fluorescein isothiocyanateFolate receptor-alpha-targeted imaging agent - OnTarget LaboratoriesFolate receptor-alpha-targeted fluorescent agent - OnTarget LaboratoriesFolate-FITC conjugateFolate-5-fluorescein isothiocyanate +[12] 
ClassificationDiagnostic agent (In vivo) > Contrast agentSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiagnostic imaging enhancersFolate receptor alpha modulators
TargetsFolate receptor alpha
Therapy Area/IndicationsInflammatory Bowel DiseasesArthritis, RheumatoidGenital Neoplasms, Female +[11] 
Global Approved IndicationsOvarian Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/11/29
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOn Target Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center GroningenUniversity of California IrvineOn Target Laboratories Inc +[5] 
Inactive CompaniesUniversity Of Pennsylvania
Active IndicationsInflammatory Bowel DiseasesArthritis, RheumatoidGenital Neoplasms, Female +[8] 
Inactive IndicationsPituitary NeoplasmsBreast NeoplasmsNeoplasms

Other Information

ATC CodeV09I
Related LinksDrugBank